Gsa Capital Partners LLP Tff Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.99 - $7.22 $46,718 - $84,538	-11,709 Reduced 11.11%	93,679 $529,000
Q1 2022 May 11, 2022	SELL	$5.28 - $9.17 $125,943 - $218,732	-23,853 Reduced 18.46%	105,388 $665,000
Q4 2021 Feb 14, 2022	SELL	$6.86 - $9.65 $110,130 - $154,921	-16,054 Reduced 11.05%	129,241 $1.15 Million
Q3 2021 Nov 12, 2021	BUY	$7.21 - $10.49 $490,366 - $713,445	68,012 Added 88.0%	145,295 $1.12 Million
Q2 2021 Aug 05, 2021	BUY	$8.48 - $13.61 $655,359 - $1.05 Million	77,283 New	77,283 $743,000

Ticker TFFP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,477,800
Market Cap $8.92M
Description
TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing (TFF) technology platform in the United States and Australia. It intends to focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and condit...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.